cetirizine has been researched along with Allergy, Drug in 12 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with recurrent idiopathic urticaria reported exacerbations after treatment with cetirizine." | 7.71 | Urticaria to cetirizine. ( Bartra, J; Gaig, P; Garcia-Ortega, P; Tella, R, 2002) |
| "A patient with recurrent idiopathic urticaria reported exacerbations after treatment with cetirizine." | 3.71 | Urticaria to cetirizine. ( Bartra, J; Gaig, P; Garcia-Ortega, P; Tella, R, 2002) |
| "Cetirizine, 2." | 2.67 | Compared peripheral H1 inhibiting effects of cetirizine 2 HCl and loratadine. ( Coulie, P; Ghys, L; Rihoux, JP, 1990) |
| "Cetirizine appears to be a viable substitute for diphenhydramine for the prevention of infusions reactions with cetuximab, paclitaxel, and rituximab infusions in adults." | 1.51 | Cetirizine versus diphenhydramine in the prevention of chemotherapy-related hypersensitivity reactions. ( Durham, CG; Foster, J; Herrington, JD; Sager, L; Thotakura, D, 2019) |
| "Cetirizine was incorporated into small unilamellar vesicles (SUV) and multilamellar vesicles (MLV) prepared using L-alpha-phosphatidylcholine, and into Glaxal Base (GB), used as the control." | 1.32 | Cetirizine from topical phosphatidylcholine liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model. ( Elzainy, AA; Gu, X; Simons, FE; Simons, KJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanaoka, T | 1 |
| Matsuoka, K | 1 |
| Shaker, M | 1 |
| Chan Ng, P | 1 |
| Huang, CH | 1 |
| Rajakulendran, M | 1 |
| Tan, MM | 1 |
| Wang, PP | 1 |
| Tay, LQ | 1 |
| Goh, SY | 1 |
| Shek, LP | 1 |
| Tham, EH | 1 |
| Durham, CG | 1 |
| Thotakura, D | 1 |
| Sager, L | 1 |
| Foster, J | 1 |
| Herrington, JD | 1 |
| Foer, D | 1 |
| Marquis, K | 1 |
| Romero, N | 1 |
| Castells, MC | 1 |
| Rutkowski, K | 1 |
| Wagner, A | 1 |
| Tella, R | 1 |
| Gaig, P | 1 |
| Bartra, J | 1 |
| Garcia-Ortega, P | 1 |
| Abraham, D | 1 |
| Saltoun, CA | 1 |
| Elzainy, AA | 1 |
| Gu, X | 1 |
| Simons, FE | 1 |
| Simons, KJ | 1 |
| Tedeschi, A | 1 |
| Lorini, M | 1 |
| Suli, C | 1 |
| Cugno, M | 1 |
| Schrijvers, D | 1 |
| Wanders, J | 1 |
| Dirix, L | 1 |
| Prove, A | 1 |
| Vonck, I | 1 |
| van Oosterom, A | 1 |
| Kaye, S | 1 |
| Eapen, SS | 1 |
| Connor, EL | 1 |
| Gern, JE | 1 |
| Rihoux, JP | 1 |
| Ghys, L | 1 |
| Coulie, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Feasibility of a Randomized Controlled Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel[NCT04237090] | Phase 3 | 27 participants (Actual) | Interventional | 2020-02-14 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for cetirizine and Allergy, Drug
| Article | Year |
|---|---|
Coping with toxicities of docetaxel (Taxotere).
Topics: Antineoplastic Agents, Phytogenic; Cetirizine; Docetaxel; Drug Hypersensitivity; Edema; Humans; Keto | 1993 |
Compared peripheral H1 inhibiting effects of cetirizine 2 HCl and loratadine.
Topics: Adult; Cetirizine; Cyproheptadine; Double-Blind Method; Drug Hypersensitivity; Female; Histamine; Hi | 1990 |
10 other studies available for cetirizine and Allergy, Drug
| Article | Year |
|---|---|
Safe and effective intradermal influenza vaccine desensitization for delayed influenza vaccine allergy.
Topics: Adolescent; Anti-Allergic Agents; Cetirizine; Desensitization, Immunologic; Drug Administration Sche | 2018 |
Successful desensitization to gonadotropin-releasing hormone analogue triptorelin acetate using a sustained-release depot preparation.
Topics: Anti-Allergic Agents; Antineoplastic Agents, Hormonal; Cetirizine; Child; Delayed-Action Preparation | 2018 |
Cetirizine versus diphenhydramine in the prevention of chemotherapy-related hypersensitivity reactions.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Agents, Phytogenic; Cetirizine; Cetuximab | 2019 |
Challenges and safety of beta-lactam desensitization during extracorporeal membrane oxygenation.
Topics: Acetates; Allergens; Anaphylaxis; Anti-Infective Agents; Antibiotic Prophylaxis; beta-Lactams; Cetir | 2019 |
Cetirizine anaphylaxis.
Topics: Anaphylaxis; Animals; Anti-Allergic Agents; Cetirizine; Drug Hypersensitivity; Female; Humans; Middl | 2014 |
Urticaria to cetirizine.
Topics: Adult; Cetirizine; Drug Hypersensitivity; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Ur | 2002 |
Facial swelling and eosinophilia in a 44-year-old woman.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Angioedema; Cefuroxime; Cetirizine; Diagnosis, Diffe | 2002 |
Cetirizine from topical phosphatidylcholine liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.
Topics: Administration, Topical; Animals; Anti-Allergic Agents; Area Under Curve; Cetirizine; Drug Hypersens | 2004 |
Detection of serum histamine-releasing factors in a patient with idiopathic anaphylaxis and multiple drug allergy syndrome.
Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; Biomarkers, Tumor; Cetirizine; Drug Hypersensitivity; Fem | 2007 |
Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child.
Topics: Cetirizine; Child, Preschool; Desensitization, Immunologic; Diabetes Mellitus, Type 1; Drug Hypersen | 2000 |